Topic

Articles

BIA and Clarivate have released data showing that UK biotech companies are set to experience another strong year for fundraising in 2021.

UK Biotech Experiences Strong Start to 2021 Fundraising

 Washington Editor, jillwechsler7@gmail.com.

The need for added revenues to fund billion-dollar infrastructure improvements has fueled challenges to industry pricing practices. 

Drug Pricing Moves to Top of Legislative Agenda

The Federal Trade Commission is launching a broad review of drug-company mergers, with an eye to examining how such actions can harm competition in the biopharmaceutical industry. 

FTC Eyes Crackdown on Pharma Mergers

Saroj Ramdas is GSK fellow and director, CMC regulatory strategy and advocacy with GlaxoSmithKline.

Renata Varga is principal scientist, Teva Branded Pharmaceutical Products R&D, Inc.

Martin Gastens is senior director program management, AbbVie Deutschland GmbH & Co. KG.

Twinkle R. Christian is process development scientist at Amgen.

Bharat Jagannathan is process development senior scientist at Amgen.

Barbara Rellahan, rellahan@amgen.com, is director, product quality, at Amgen.

Jillian Brady is manager, science, regulation & policy, Faegre Drinker Biddle & Reath LLP.

Many biologic drug manufacturers encounter similiar challenges; precompetitive collaboration can help resolve these issues. Representatives of the IQ Consortium’s Biologics CMC Leadership Group describe efforts to address the safe handling of biologic drugs in closed-system transfer devices in healthcare settings and the need for phase-appropriate specifications.

Overcoming Challenges to Biopharmaceutical Development and Manufacture with Science- and Risk-Based Strategies

Feliza Mirasol is the science editor for 

A growing pipeline of gene therapy candidates aimed at treating neurodegenerative diseases has prompted new guidance.

Gene Therapies Target Neurodegenerative Diseases

This agreement enhances GSK’s investment in cell and gene therapy manufacturing in the UK for clinical trials.

GSK Expands Clinical Trial Manufacturing Capacity for Cell and Gene Therapy at Catapult UK Facility

The companies intend to design and implement algorithms for the early stages of research for drug discovery and development of drug candidates to treat Alzheimer’s disease.

Roche and Cambridge Quantum Computing Use Algorithms for Early Alzheimer's Drug Research

The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.

SPT Labtech Strengthens Automation Services with BioMicroLab Acquisition

The acquisition will integrate drug substance, drug product, and clinical testing capabilities under Quotient.

Quotient Sciences Acquires CDMO Arcinova

Salipro Biotech has been granted a European Patent for its novel method of direct extraction of membrane proteins and for the generation of libraries with Salipro particles.

BioBusiness